www.fdanews.com/articles/133954-eu-approves-astrazeneca-8217-s-nasal-flu-vaccine-for-children

EU Approves AstraZeneca’s Nasal Flu Vaccine for Children

February 2, 2011

AstraZeneca’s nasal flu vaccine has been approved for use in Europe in children aged from two up to 18 years and is likely to be available for the 2012/13 influenza season, the drugmaker said.
CNBC